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Abstract 
Objective: We investigated whether responses about possible scientific misconduct from journals to journalists 
would differ in speed, usefulness, and tone from responses to academics. Twelve journals that published 23 clinical tri-
als about which concerns had been previously raised were randomly assigned to enquiries by a journalist or academ-
ics. Emails were sent every 3 weeks to the journal editor. We recorded the time for the journal to respond, and two 
investigators independently assessed the usefulness and tone of the journal responses.
Results: 10/12 journals responded: 3 after one email, 5 after two emails, and 2 after three emails (median time 
from first email to response: 21 days; no difference in response times to journalist or academics, P = 0.25). Of the 10 
responses, 8 indicated the journal was investigating, 5 had a positive tone, 4 a neutral tone, and 1 a negative tone. Five 
of the enquiries by the academics produced information of limited use and 1 no useful information, whereas none 
of the 6 journalist enquiries produced useful information (P = 0.015). None of the 10 responses was considered very 
useful. In conclusion, journal responses to a journalist were less useful than those to academics in understanding the 
status or outcomes of journal investigations.
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Introduction
When scientific misconduct occurs, the relevant litera-
ture ought to be promptly corrected. However, there are 
often lengthy delays between concerns being raised and 
formal actions such as expression of concern notices 
or article retraction (see Table  1 for description). For 
example, concerns were raised about the work of the 
Japanese anaesthetist Yoshitaka Fujii in 2000 [1] but 
it took until 2012 before the body of work was publicly 
confirmed as fraudulent leading to the recommenda-
tion that 183 randomised controlled trials (RCTs) be 
retracted [2, 3]. Delays may occur for many reasons, but 
one common theme is that formal investigations take a 
very long time. The average duration of investigation by 
the Office of Research Integrity between 2001 and 2010 
was 20 months, with some investigations lasting at least 
9 years [4]. Other concerns raised about the management 
of scientific misconduct include uninformative retraction 
notices and failure to retract articles even when there is 
clear evidence of misconduct [4].
Beginning in March 2013, we started to report to 
affected journals numerous concerns about a set of 33 
RCTs from a group in Japan, including objective statisti-
cal evidence of implausible characteristics of randomised 
treatment groups, improbable recruitment rates and 
implausibly positive outcome data, lack of ethical over-
sight, plagiarism and many logical and other errors. 
Between October 2015 and September 2016, 10 RCTs 
were retracted based upon these concerns. The reasons 
for retraction included scientific misconduct, concerns 
about data integrity, fraud, extensive self-plagiarism and 
honorary authorship. In November 2016, our system-
atic review describing the concerns about the RCTs was 
published [7]. An accompanying editorial stated that the 
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lead author admitted that the three RCTs in that journal 
were fraudulent, and that the editors of the journals that 
published the remaining RCTs had been notified of the 
concerns [8]—these notifications occurred in September 
2016.
We expected that a number of other retractions would 
follow this publication and the journal notifications, but 
4 months later we had received no new information and 
nothing further had happened in public. The journal that 
published our systematic review indicated that it had 
completed its involvement. Therefore, we planned to 
contact each journal with unretracted RCTs to ask for an 
update, in the hope of expediting processes to preserve 
the integrity of the research literature. Previously, we had 
found that our enquiries to journals about their investi-
gations of our concerns generated responses of variable 
timing, usefulness and tone. We wondered if it would 
make any difference whether the enquiry to the journal 
came from an academic group or a journalist. Therefore, 
we invited a journalist (SB) who has recently investigated 
and written about scientific misconduct and the world 
of academic publishing for the Guardian newspaper [9–
11] to take part in a randomised comparison of journal 
responses to contact by academics or a journalist. Spe-
cifically, we hypothesized that journal responses to jour-
nalists would differ in speed, usefulness, and tone from 
journal responses to academics.
Main text
Methods
We contacted the editors of the 12 journals that pub-
lished the 23 unretracted trial publications using email 
contact details on the journal website, or where these 
were not available or not responded to, using email 
details obtained from an internet search. Each journal 
was randomised to receive a standard letter from the 
journalist or from our group of academics (Additional 
file  1: Appendix S1). Journals were randomised in two 
blocks, one block for each of the two first authors on 
the 23 publications, using random numbers generated 
with Excel 2010. Thus, six journals with between 1 and 3 
publications each (total 12 publications) were sent a let-
ter from the journalist and six journals with between 1 
and 4 publications each (total 11 publications) were sent 
a letter from the academics. Each journal editor was con-
tacted contemporaneously by email, and if no response 
was received within 3 weeks, a follow-up email was sent. 
We sent a maximum of 3 emails in total.
We recorded basic facts about each of the journals, 
including the publisher, impact factor, and whether the 
journal was a member of the Committee on Publica-
tion Ethics (COPE), who provide guidance for dealing 
with scientific misconduct, or had previous experience 
with retractions, as determined by Pubmed and Google 
searches. For each journal, we recorded the time taken 
to respond and any details provided about investigations 
being undertaken. Two authors blinded to randomisa-
tion (AG, AA) independently classified the usefulness of 
information provided in the responses, and the tone of 
the journal response. We pre-specified that a very useful 
response would clearly state what the journal had done to 
date and the current status of its investigation; whereas a 
response of no use would not indicate what the journal 
had done nor the current status of the investigation, and 
Table 1 Definition of scientific misconduct and COPE guidelines for journal responses to errors or misconduct (Adapted 
from [6])
COPE Committee on Publication Ethics
Definition of scientific misconduct
Fabrication, falsification, or plagiarism in proposing, performing or reviewing research, or in reporting research results [5]
COPE guidelines
Problem Recommended action
A small part of otherwise reliable publication is misleading (especially if honest error) Correction
Incorrect author list
Inconclusive evidence of research or publication misconduct Expression of concern
Evidence that findings are unreliable but authors’ institution will not investigate
Believe an investigation has not been, or would not be, fair and impartial or conclusive
An investigation is underway but results not be available for some time
Clear evidence that findings are unreliable because of misconduct or honest error Retract publication
Findings have been published previously
Plagiarism
Research is unethical
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a response of limited use would lie between these two 
categories. Tone of the response, defined by the Oxford 
English dictionary as “The general character or attitude 
of a piece of writing”, was classified as positive, negative 
or neutral by each investigator according to their own 
judgement. Agreement of these classifications between 
authors was 75%-kappa statistic for usefulness 0.64, and 
for tone 0.53. In cases of disagreement, the independent 
assessment of a third author (MB) acted as a tiebreaker, 
with final categorisation agreed by consensus.
We compared the median time to a response using the 
log-rank test and the differences in usefulness and tone 
with Fisher’s Exact test (GraphPad Prism version 7.03 for 
Windows, GraphPad Software, La Jolla California USA, 
https ://www.graph pad.com). P < 0.05 was considered sta-
tistically significant.
Due to the nature of the study, ethical approval was not 
considered necessary.
Results
The 23 unretracted trial publications were published in 
12 journals from 8 different publishers (Additional file 1: 
Appendix Table  S1). Three journals are open access, 7 
are members of COPE, 11 have an impact factor, which 
ranges from 1.2 to 5.79, and 8 have prior experience with 
retractions.
Ten of the 12 journals responded, 3 after the first email, 
5 after the second email, and 2 after the third email. 8 
journals responded within 1 day of the most recent email 
being sent. Thus, the median time from the first email 
to a response was 21  days. There was no difference in 
response times between the two groups (P = 0.25).
Table 2 shows details of the responses received (Addi-
tional file  2). Of the 10 responses, 8 indicated that the 
journal was investigating, 4 whether or not the lead 
author had been contacted, and 1 whether or not the 
institution had been contacted. Only 3 responses indi-
cated that the journal would be in contact in the future, 
but none made contact within 5 months of the journal’s 
response.
Overall, we considered that 5 of the 6 enquires made 
by academics produced information of limited use and 1 
no useful information, whereas none of the 6 enquiries by 
the journalist produced useful information (P = 0.015). 
None of the 10 responses were considered to be very 
useful. Table  3 has examples of the responses and their 
Table 2 Journal responses
a Includes 2 journals who did not respond to 3 emails
Journal contacted by Academics (n = 6) Journal contacted 
by Journalist 
(n = 6)
Publications (n) 11 12
Response from journal 6 4
Response indicates: (Yes/no/not stated)
 Journal is investigating 6/0/2 2/0/2
 Author contacted 3/1/2 0/0/4
 Institution contacted 0/1/5 0/0/4
 Journal will be in contact in future 1/2/3 2/0/2
Consensus assessment
 Tone (positive/neutral/negative) 4/2/0 1/2/1
 Information obtained (useful/ limited use/no use) 0/5/1 0/0/6a
Table 3 Examples of journal responses and classification
Response Classification
We have no comment Negative tone/no use
Your email was forwarded to me. We’re still looking into this matter per our policies Neutral tone/no use
I have forwarded your e-mail to the editor and will keep you posted regarding the same Neutral tone/no use
Sorry for the delay in responding—for some reason your earlier emails did not get through to me… we have been working 
on this issue for some time now. The … managing editor … has been working with … staff as there is a defined process 
they need to follow. She is looking into where we stand with this and I will follow up with you once I learn more
Positive tone/no use
Thanks very much for your message regarding the two papers published in … Yes, the … has initiated an investigation using 
the COPE guidelines. The results of this investigation will guide our future actions
Positive tone/limited use
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classification. The tone of the journal reply was positive 
for 5 responses, neutral for 4 responses, and negative in 
1 response. There was no difference between the propor-
tion of positive/neutral (versus negative) responses to the 
academics and the journalist (P = 0.40).
One of the 23 publications was retracted because of sci-
entific misconduct in the 5 months after our initial emails 
(Additional file  1: Appendix Table  S1), but no public 
statements or expressions of concern were issued about 
any of the remaining 22 publications during this period.
Discussion
Journals responded to enquiries by academics with more 
useful information, (although that information was still 
of limited use), than they provided to the journalist, but 
there were no differences in the tone or speed of the jour-
nal response to the academics or journalist. These find-
ings were contrary to some of our expectations. Prior to 
the study, we had a range of views as to whether there 
would be differences in journal responses to being con-
tacted by a journalist or by a group of academics, in gen-
eral expecting either no differences or that the journalist 
would receive faster responses.
Only 25% of journals (3/12) responded to the initial 
email contact, and 17% (2/12) did not respond despite 
being sent 3 separate emails. When journals did reply, the 
response was quick: 8/10 responses came within 1 day of 
the most recent email, and the other two within 8  days 
of the most recent email. However, the information pro-
vided by the journals was of limited or no use in under-
standing what was happening. While 8/10 responses 
indicated that an investigation was taking place, only 4 
indicated whether or not the author had been contacted 
and only 1 whether or not the institution had been con-
tacted. Three responses stated that we could expect 
further contact from the journal, but none gave an indi-
cation of the expected time frame and no journal has 
contacted us as yet. Despite our enquiries, the investiga-
tions of the possible misconduct did not appear to have 
proceeded: in the 11  months after the journals were all 
first notified by another journal editor about the possible 
scientific misconduct (including the 5  months after our 
first email) only one journal made any public statement 
about the integrity of an RCT—it was retracted.
Unbeknown to us, a journalist from the Retraction 
Watch website also contacted the journals with the 
unretracted papers between our 2nd and 3rd email 
contacts [12]. Retraction Watch is a prominent web-
site that publicly records and comments upon scientific 
misconduct, and regularly corresponds with journals 
about misconduct. Therefore, its journalists might be 
expected to obtain more useful information more fre-
quently than other journalists or academics. Of the 12 
journals potentially contacted, 7 responded to Retrac-
tion Watch. Applying the same classifications we used, 
2 responses were very useful, 2 of limited use, and 3 of 
no use. One response stated that the journal, a member 
of COPE, did not investigate issues of misconduct. This 
independent attempt at contacting journals confirms 
that journals often do not respond, and when they do, 
the information provided is usually of limited or no use.
Our study has highlighted an important problem. 
When there is clear-cut evidence of research misconduct 
identified in previous investigations, there seems little 
reason for long delays or a reluctance to provide useful 
information about the processes being undertaken to 
correct the scientific record, nor to promptly publish an 
expression of concern. But even after recommendation 
for retraction following an official investigation by a Ger-
man State Medical Association, 10% of articles remained 
unretracted after 2  years [13]. Failure to express con-
cern or retract articles means that patients and research 
participants may be put at risk if they receive treatment 
based on findings that are later retracted because they 
were incorrect or unreliable and research funds may be 
wasted by exploring hypotheses based on invalid data.
Limitations
The major limitations to our findings arise from the nec-
essarily small and selected group of journals contacted. 
By necessity, the study focused only on a group of 23 
RCTs published in 12 journals. These RCTs were part of a 
broader group of 33 RCTs about which concerns regard-
ing possible scientific misconduct had been published 
[7]. All the affected journal editors had been notified of 
the concerns by the editor of the journal that published 
these concerns [8]. It would be valuable to repeat the 
study with a larger number and broader range of journals. 
However, potential widespread scientific misconduct is 
rare, and an opportunity for independent investigators to 
repeat our study might not occur for some time.
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